PCOS: two body shape indices are higher, with no evidence of diagnostic usefulness

Body shape indices can differ between two groups without enabling a disease to be diagnosed. A systematic review with meta-analysis reports higher ABSI and BRI values in women with polycystic ovary syndrome (PCOS). But the studies are observational and their results highly heterogeneous.

Illustration of the body shape indices studied in women with and without PCOS.
NutritionEditorial illustration, not study data.

A synthesis of nine observational studies

The authors searched five bibliographic databases for studies. Their review, registered in PROSPERO, includes two case-control studies and seven cross-sectional studies comparing women with and without PCOS.

The analyses cover two body shape indicators: ABSI, short for A Body Shape Index, and BRI, short for Body Roundness Index. Eight studies, totaling 3,193 participants, contribute to the ABSI analysis. Five studies, involving 840 participants, contribute to the BRI analysis. Study duration is not specified in the available abstract.

Average differences, but substantial variability

For BRI, the standardized mean difference between groups is 1.09, with a 95% confidence interval ranging from 0.53 to 1.66. This measure expresses a difference between groups, not a threshold usable for an individual.

ABSI is also higher on average among participants with PCOS. However, its statistical significance depends on the removal of certain studies. The BRI result remains statistically significant when each study is removed from the analysis in turn.

This stability does not eliminate uncertainty: heterogeneity reaches 85.9% for BRI and 90.5% for ABSI. Results therefore vary substantially from one study to another.

No demonstrated superiority over BMI

Body mass index is also higher in women with PCOS in the reported analyses. The abstract does not establish whether ABSI or BRI provides additional clinical information beyond BMI.

Nor do these comparisons show that the indices predict the onset of PCOS, cause it, or that lowering them would improve symptoms. They also provide no diagnostic performance data that would support recommending their use for screening.

Limitations to keep in mind

Only the PubMed abstract was consulted, not the full text. The studies are observational, with high heterogeneity and an ABSI result sensitive to the exclusion of certain studies. The authors call for more data from other regions of the world and covering different clinical stages. Funding and conflicts of interest were not checked.

What we can take away

This synthesis documents an association between PCOS and higher body shape indices. It is not enough to establish ABSI or BRI as a diagnostic or monitoring tool.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.